Cigarette smoking activates immune cells called neutrophils to release inflammatory substances that spread throughout your body and accelerate heart disease, even when smoke is swallowed rather than inhaled. According to Gram Research analysis, this 2026 study in mice showed that smoking triggers bone marrow to produce excess immune cells and impairs the body’s ability to clean up damaged tissue in artery plaques, dramatically speeding up atherosclerosis progression. Blocking the specific inflammatory protein responsible for these effects (S100A8/A9) prevented the cardiovascular damage, proving this is a direct cause-and-effect mechanism rather than just an association.
Cigarette smoking doesn’t just hurt your lungs—it triggers a chain reaction in your body that damages your heart and blood vessels. According to Gram Research analysis, scientists discovered that smoking activates special immune cells called neutrophils, which release inflammatory substances that spread throughout your body. These substances make your bone marrow produce more immune cells and cause inflammation in your arteries, speeding up the buildup of plaque that leads to heart disease. The research shows this happens even when smoke is swallowed rather than inhaled, revealing a new way smoking harms your cardiovascular system.
Key Statistics
A 2026 research article in Circulation Research found that cigarette smoke exposure increased circulating neutrophils and monocytes through enhanced bone marrow myelopoiesis and elevated reactive oxygen species-dependent S100A8/A9 release in laboratory mice.
In mice genetically bred to develop atherosclerosis, cigarette smoke extract accelerated plaque progression by promoting inflammasome-primed neutrophil infiltration and increasing IL-1β release, effects that were completely prevented by using bone marrow from mice lacking the S100a9 gene.
Oral administration of cigarette smoke extract reproduced the same immune cell activation and inflammatory effects as inhaled smoke exposure, demonstrating that tobacco’s cardiovascular toxicity extends beyond inhalation to include ingested smoke components.
The Quick Take
- What they studied: How cigarette smoking triggers immune cells in your body to cause heart and blood vessel damage, even beyond what happens in your lungs
- Who participated: Laboratory mice exposed to cigarette smoke or cigarette smoke extract, including specially bred mice without certain immune proteins to test cause-and-effect relationships
- Key finding: Smoking activates immune cells called neutrophils to release inflammatory substances (S100A8/A9) that travel through the bloodstream, increase bone marrow activity, and accelerate plaque buildup in arteries—and this happens even when smoke components are swallowed rather than inhaled
- What it means for you: Smoking damages your heart through multiple pathways beyond lung damage. This suggests that even non-inhalation tobacco exposure poses cardiovascular risks. If you smoke or use tobacco products, quitting reduces this systemic inflammation and heart disease risk. This research strengthens the case for comprehensive smoking cessation.
The Research Details
Scientists exposed laboratory mice to cigarette smoke through inhalation or gave them cigarette smoke extract by mouth. They then examined immune cells in multiple locations—lungs, blood, spleen, and bone marrow—using specialized flow cytometry technology that identifies and counts different cell types. They measured inflammatory markers and reactive oxygen species (harmful molecules produced during inflammation). In a separate experiment, they used mice genetically bred to develop atherosclerosis (plaque buildup in arteries) and tracked how cigarette smoke extract affected plaque progression. Finally, they performed bone marrow transplants using mice lacking a specific inflammatory protein (S100a9) to prove this protein was responsible for the harmful effects.
This multi-pronged approach allowed researchers to trace the exact pathway from smoke exposure to heart damage. By testing both inhaled and ingested smoke, they showed the effect wasn’t just from lung inflammation but from direct activation of immune cells throughout the body. The bone marrow transplant experiments provided strong evidence that one specific inflammatory substance was the key culprit.
The research design is particularly valuable because it moves beyond simply showing that smoking causes heart problems—it reveals the specific biological mechanism. This type of mechanistic research helps scientists understand why smoking is harmful and potentially how to intervene.
Previous research established that smoking causes heart disease, but the exact biological pathway remained unclear. This study fills that gap by identifying neutrophils and their inflammatory products as a critical link between smoking exposure and cardiovascular damage. Understanding the mechanism is important because it could lead to new treatments and helps explain why smoking is so dangerous even in small amounts. The finding that oral exposure (swallowing smoke components) causes the same damage as inhalation is particularly significant because it suggests multiple routes of tobacco exposure pose cardiovascular risks.
This research was published in Circulation Research, a highly respected peer-reviewed journal focused on cardiovascular science. The study used multiple complementary approaches (exposure studies, immune cell analysis, atherosclerosis models, and genetic manipulation) rather than relying on a single method, which strengthens confidence in the findings. The use of genetically modified mice to prove cause-and-effect is a gold standard in biological research. However, because this is animal research, the findings need confirmation in human studies before making definitive claims about human health. The study was well-designed with appropriate controls, but animal models don’t always perfectly predict human responses.
What the Results Show
Cigarette smoke exposure caused a significant increase in neutrophils (a type of white blood cell) circulating in the bloodstream. This increase occurred because smoking stimulated the bone marrow to produce more of these immune cells—a process called myelopoiesis. The mechanism involved reactive oxygen species, which are harmful molecules that accumulate during inflammation and trigger neutrophils to release S100A8/A9, inflammatory proteins that act like alarm signals in your body.
When researchers gave mice cigarette smoke extract by mouth (without any lung exposure), the same cascade occurred. This was a crucial finding because it showed the effect wasn’t dependent on inhaling smoke into the lungs—the smoke components directly activated immune cells throughout the body. This suggests that any tobacco exposure, including chewing tobacco or other ingested forms, could trigger this harmful pathway.
In mice bred to develop atherosclerosis (plaque buildup in arteries), cigarette smoke extract dramatically accelerated disease progression. The smoke caused more neutrophils to infiltrate the artery walls, increased production of IL-1β (a powerful inflammatory molecule), and impaired the cleanup process that normally removes dead cells from plaques. This combination created a perfect storm for rapid plaque accumulation.
Most convincingly, when researchers transplanted bone marrow from mice lacking the S100a9 gene (the gene that produces one of the key inflammatory proteins), the harmful effects of cigarette smoke disappeared. Myelopoiesis normalized, vascular inflammation decreased, and plaque burden was reduced. This proved that S100A8/A9 was not just associated with the damage—it was actually causing it.
The research revealed that cigarette smoke impairs macrophage efferocytosis, which is the process where immune cells clean up dead cells in plaques. This impairment means that damaged tissue accumulates rather than being cleared away, worsening plaque stability. Additionally, the study showed that inflammasome-primed neutrophils (neutrophils that have been activated by inflammatory signals) were specifically increased in atherosclerotic plaques, suggesting these cells are particularly dangerous in the context of existing cardiovascular disease. The research also demonstrated that reactive oxygen species production was essential for the inflammatory cascade, indicating that oxidative stress is a critical mechanism linking smoking to heart disease.
Previous research established that smoking causes systemic inflammation and accelerates atherosclerosis, but the specific cellular and molecular mechanisms remained poorly understood. This study builds on that foundation by identifying neutrophils and S100A8/A9 as key players in the pathway. Earlier work showed that these inflammatory proteins are elevated in smokers, but this research proves they directly cause cardiovascular damage rather than just being markers of inflammation. The finding that oral exposure causes cardiovascular effects is novel and extends our understanding beyond inhalation-based smoking. This research also connects lung inflammation research with cardiovascular research, showing how effects in one organ system drive disease in another.
This research was conducted entirely in laboratory mice, which don’t perfectly replicate human biology or smoking behavior. Mice were exposed to concentrated cigarette smoke extract rather than the complex mixture of thousands of chemicals in actual cigarette smoke, so some effects might differ in real-world smoking. The study didn’t examine long-term effects or dose-response relationships (whether more smoking causes proportionally more damage). Additionally, while the research proves the mechanism in mice, it doesn’t yet show whether blocking S100A8/A9 would be an effective treatment in humans. The study also didn’t examine individual variations in susceptibility—some people may be more or less affected by these mechanisms based on genetics or other factors. Finally, the research focused on one specific inflammatory pathway; smoking likely causes cardiovascular damage through multiple mechanisms not addressed in this study.
The Bottom Line
If you smoke, the strongest evidence-based recommendation is to quit completely. This research provides additional biological evidence for why smoking cessation is critical for heart health. For people who have already quit, this research suggests that the cardiovascular benefits of quitting extend to reducing this specific inflammatory pathway. For non-smokers, avoiding secondhand smoke exposure is advisable based on this mechanism, though the research focused on direct exposure. Healthcare providers might consider monitoring inflammatory markers in smokers as part of cardiovascular risk assessment. High confidence: Smoking cessation reduces cardiovascular disease risk through multiple mechanisms including this inflammatory pathway. Moderate confidence: The specific findings about S100A8/A9 may eventually lead to new treatments, but such treatments are not yet available.
Current smokers should care most about this research, as it provides biological evidence that smoking damages the heart through multiple pathways. People with existing cardiovascular disease or family history of heart disease should be especially motivated by this research to avoid smoking. Healthcare providers treating cardiovascular disease should understand this mechanism to better counsel patients about smoking cessation. People exposed to secondhand smoke may also be affected, though the research focused on direct exposure. This research is less immediately relevant to people who have never smoked and have no cardiovascular risk factors, though it reinforces general public health messages about smoking.
The inflammatory cascade described in this research begins relatively quickly after smoke exposure—the study showed increased neutrophils and inflammatory markers within the timeframe of the experiments (likely days to weeks). However, atherosclerosis progression takes longer; the accelerated plaque buildup in the study was observed over weeks to months in mice. In humans, cardiovascular benefits of quitting smoking typically begin within weeks (improved blood vessel function) but take months to years for full reduction in heart attack and stroke risk. The inflammatory markers measured in this study could potentially improve within days to weeks of quitting, though human studies would be needed to confirm this timeline.
Frequently Asked Questions
How does smoking damage your heart besides affecting your lungs?
Smoking activates immune cells called neutrophils to release inflammatory substances that travel through your bloodstream, causing bone marrow to produce excess immune cells and triggering inflammation in artery walls. This accelerates plaque buildup and impairs your body’s ability to clean up damaged tissue in plaques, directly damaging your cardiovascular system independent of lung effects.
Can swallowing tobacco smoke components cause the same heart damage as inhaling?
Yes, according to this 2026 research, oral exposure to cigarette smoke extract triggered the same immune cell activation and inflammatory cascade as inhaled smoke. This suggests that any tobacco exposure route—including chewing tobacco or ingested smoke—poses cardiovascular risks through this inflammatory mechanism.
What is the specific inflammatory protein that causes smoking-related heart disease?
S100A8/A9 is the key inflammatory protein. When neutrophils are activated by smoking, they release S100A8/A9, which acts as an alarm signal triggering systemic inflammation, bone marrow activation, and accelerated atherosclerosis. Blocking this protein completely prevented cardiovascular damage in the study.
How quickly does smoking damage your heart through this inflammatory pathway?
The inflammatory cascade begins relatively quickly—immune cell activation and inflammatory marker increases occurred within days to weeks in the study. However, atherosclerosis progression takes longer. In humans, cardiovascular benefits of quitting typically begin within weeks but take months to years for full risk reduction.
Could this research lead to new treatments for smokers’ heart disease?
Potentially yes. The research identifies S100A8/A9 as a specific target that, when blocked, prevented cardiovascular damage. However, this is animal research; human clinical trials would be needed to develop and test treatments. Currently, smoking cessation remains the most effective intervention.
Want to Apply This Research?
- Track daily smoking or tobacco use (number of cigarettes, cigars, or other products) alongside cardiovascular health markers like resting heart rate and blood pressure. This creates a visible connection between smoking behavior and heart health metrics, helping users see the direct impact of their tobacco use on their cardiovascular system.
- Set a specific quit date and use the app to track days smoke-free. Create daily reminders about the cardiovascular inflammation mechanism—understanding that each cigarette triggers an inflammatory cascade may increase motivation. Log cravings and use the app to record what triggers them, helping identify patterns and develop alternative coping strategies.
- For current smokers: Track smoking frequency, resting heart rate, and blood pressure daily to establish baseline and monitor changes. For people quitting: Track days smoke-free, cravings intensity, and cardiovascular metrics (heart rate, blood pressure) to visualize improvements. For former smokers: Monitor cardiovascular health metrics monthly to track long-term benefits. Use the app to set cardiovascular health goals and celebrate milestones in smoking cessation, reinforcing the connection between quitting and improved heart health.
This research was conducted in laboratory mice and has not yet been confirmed in human studies. While the findings provide important biological insights into how smoking damages the cardiovascular system, individual human responses may differ. This information is for educational purposes and should not replace professional medical advice. If you smoke or use tobacco products, consult with a healthcare provider about smoking cessation strategies and cardiovascular risk assessment. People with existing heart disease or cardiovascular risk factors should discuss smoking and health risks with their healthcare team. This research does not constitute medical diagnosis or treatment recommendations.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.